Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 4, 2015, Pages 496-502

  Imai, Yumiko ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Influenza virus infection; Omega 3 PUFA; Protectins

Indexed keywords

ANTIVIRUS AGENT; ARACHIDONATE 15 LIPOXYGENASE; CD59 ANTIGEN; MESSENGER RNA; OMEGA 3 FATTY ACID; ARACHIDONATE 12 LIPOXYGENASE; DOCOSAHEXAENOIC ACID; PROTECTIN D1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; DRUG IDENTIFICATION; DRUG SCREENING; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; ISOMER; LIPID ANALYSIS; LIPIDOMICS; MOUSE; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION; ANIMAL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; METABOLISM; SIGNAL TRANSDUCTION; VIROLOGY;

AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIVIRAL AGENTS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; DOCOSAHEXAENOIC ACIDS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84941055880     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.01.006     Document Type: Review

References (52)

1. N.M. Clark, and J.P. Lynch III Influenza: epidemiology, clinical features, therapy, and prevention Semin. Respir. Crit. Care Med. 32 2011 373 392
2. J.H. Beigel, J. Farrar, A.M. Han, F.G. Hayden, R. Hyer, M.D. de Jong, S. Lochindarat, T.K. Nguyen, T.H. Nguyen, T.H. Tran, A. Nicoll, S. Touch, and K.Y. Yuen Avian influenza A (H5N1) infection in humans N. Engl. J. Med. 353 2005 1374 1385
3. M. Imai, and Y. Kawaoka The role of receptor binding specificity in interspecies transmission of influenza viruses Curr. Opin. Virol. 2 2012 160 167
4. WHO Background and summary of human infection with influenza A (H7N9) virus http://www.who.int/influenza/human-animal-interface/latest-update-h7n9/en/ 2014
5. S. Shankaran, and G.M. Bearman Influenza virus resistance to neuraminidase inhibitors: implications for treatment Curr. Infect. Dis. 14 2012 155 160
6. A. Kumar Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life J. Antimicrob. Chemother. 66 2011 959 963
7. S. Kumar, P.L. Havens, M.J. Chusid, R.E. Willoughby Jr., P. Simpson, and K.J. Henrickson Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection Pediatr. Infect. Dis. J. 29 2010 591 594
8. A. Karlas, N. Machuy, Y. Shin, K.P. Pleissner, A. Artarini, D. Heuer, D. Becker, H. Khalil, L.A. Ogilvie, S. Hess, A.P. Maurer, E. Muller, T. Wolff, T. Rudel, and T.F. Meyer Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication Nature 463 2010 818 822
9. L. Hao, A. Sakurai, T. Watanabe, E. Sorensen, C.A. Nidom, M.A. Newton, P. Ahlquist, and Y. Kawaoka Drosophila RNAi screen identifies host genes important for influenza virus replication Nature 454 2008 890 893
10. R. Konig, S. Stertz, Y. Zhou, A. Inoue, H.H. Hoffmann, S. Bhattacharyya, J.G. Alamares, D.M. Tscherne, M.B. Ortigoza, Y. Liang, Q. Gao, S.E. Andrews, S. Bandyopadhyay, P. De Jesus, B.P. Tu, L. Pache, C. Shih, A. Orth, G. Bonamy, L. Miraglia, T. Ideker, A. Garcia-Sastre, J.A. Young, P. Palese, M.L. Shaw, and S.K. Chanda Human host factors required for influenza virus replication Nature 463 2010 813 817
11. S.D. Shapira, I. Gat-Viks, B.O. Shum, A. Dricot, M.M. de Grace, L. Wu, P.B. Gupta, T. Hao, S.J. Silver, D.E. Root, D.E. Hill, A. Regev, and N. Hacohen A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection Cell 139 2009 1255 1267
12. L. Josset, J. Tisoncik-Go, and M.G. Katze Moving H5N1 studies into the era of systems biology Virus Res. 178 2013 151 167
13. J.B. Ritter, A.S. Wahl, S. Freund, Y. Genzel, and U. Reichl Metabolic effects of influenza virus infection in cultured animal cells: intra- and extracellular metabolite profiling BMC Syst. Biol. 4 2010 61
14. S. Lin, N. Liu, Z. Yang, W. Song, P. Wang, H. Chen, M. Lucio, P. Schmitt-Kopplin, G. Chen, and Z. Cai GC/MS-based metabolomics reveals fatty acid biosynthesis and cholesterol metabolism in cell lines infected with influenza A virus Talanta 83 2010 262 268
15. C.D. Russell, and J. Schwarze The role of pro-resolution lipid mediators in infectious disease Immunology 141 2014 166 173
16. C. Cilloniz, M.J. Pantin-Jackwood, C. Ni, A.G. Goodman, X. Peng, S.C. Proll, V.S. Carter, E.R. Rosenzweig, K.J. Szretter, J.M. Katz, M.J. Korth, D.E. Swayne, T.M. Tumpey, and M.G. Katze Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection J. Virol. 84 2010 7613 7624
17. K.A. Shirey, W. Lai, L.M. Pletneva, C.L. Karp, S. Divanovic, J.C. Blanco, and S.N. Vogel Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology Mucosal Immunol. 7 2014 549 557
18. P. Genis, M. Jett, E.W. Bernton, T. Boyle, H.A. Gelbard, K. Dzenko, R.W. Keane, L. Resnick, Y. Mizrachi, and D.J. Volsky Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease J. Exp. Med. 176 1992 1703 1718
19. M. Morita, K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira, R. Iwamoto, T. Watanebe, S. Sakabe, T. Daidoji, S. Nakamura, A. Kadowaki, T. Ohto, H. Nakanishi, R. Taguchi, T. Nakaya, M. Murakami, Y. Yoneda, H. Arai, Y. Kawaoka, J.M. Penninger, M. Arita, and Y. Imai The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza Cell 153 2013 112 125
20. N.K. Rajasagi, P.B. Reddy, S. Mulik, P. Gjorstrup, and B.T. Rouse Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology Invest. Ophthalmol. Vis. Sci. 54 2013 6269 6279
21. N.K. Rajasagi, P.B. Reddy, A. Suryawanshi, S. Mulik, P. Gjorstrup, and B.T. Rouse Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1 J. Immunol. 186 2011 1735 1746
22. G. Neumann, G.G. Brownlee, E. Fodor, and Y. Kawaoka Orthomyxovirus replication, transcription, and polyadenylation Curr. Top. Microbiol. Immunol. 283 2004 121 143
23. E. De Clercq Antiviral agents active against influenza A viruses Nat. Rev. Drug Discov. 5 2006 1015 1025
24. A.N. Abdel-Ghafar, T. Chotpitayasunondh, Z. Gao, F.G. Hayden, D.H. Nguyen, M.D. de Jong, A. Naghdaliyev, J.S. Peiris, N. Shindo, S. Soeroso, and T.M. Uyeki Update on avian influenza A (H5N1) virus infection in humans N. Engl. J. Med. 358 2008 261 273
25. J.M. Schwab, N. Chiang, M. Arita, and C.N. Serhan Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874
26. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu. Rev. Immunol. 25 2007 101 137
27. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem. Rev. 111 2011 5922 5943
28. Y. Isobe, T. Kato, and M. Arita Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation Front. Immunol. 3 2012 270
29. N. Chiang, M. Arita, and C.N. Serhan Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX Prostaglandins Leukot. Essent. Fat. Acids 73 2005 163 177
30. C.N. Serhan, K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S.P. Colgan, and N.A. Petasis Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes J. Immunol. 176 2006 1848 1859
31. C.N. Serhan, J. Dalli, R.A. Colas, J.W. Winkler, and N. Chiang Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome Biochim. Biophys. Acta. S1388-1981 14 2014 00161-9
32. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.L. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037
33. J.S. Duffield, S. Hong, V.S. Vaidya, Y. Lu, G. Fredman, C.N. Serhan, and J.V. Bonventre Resolvin D series and protectin D1 mitigate acute kidney injury J. Immunol. 177 2006 5902 5911
34. M. Arita Mediator lipidomics in acute inflammation and resolution J. Biochem. 152 2012 313 319
35. T. Yamada, Y. Tani, H. Nakanishi, R. Taguchi, M. Arita, and H. Arai Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice FASEB J. 25 2011 561 568
36. B.D. Levy, P. Kohli, K. Gotlinger, O. Haworth, S. Hong, S. Kazani, E. Israel, K.J. Haley, and C.N. Serhan Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness J. Immunol. 178 2007 496 502
37. D. Sun, and C.D. Funk Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein J. Biol. Chem. 271 1996 24055 24062
38. P. Chanez, C. Bonnans, C. Chavis, and I. Vachier 15-lipoxygenase: a Janus enzyme? Am. J. Respir. Cell Mol. Biol. 27 2002 655 658
39. P. Gruter, C. Tabernero, C. von Kobbe, C. Schmitt, C. Saavedra, A. Bachi, M. Wilm, B.K. Felber, and E. Izaurralde TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus Mol. Cell 1 1998 649 659
40. A. Herold, M. Suyama, J.P. Rodrigues, I.C. Braun, U. Kutay, M. Carmo-Fonseca, P. Bork, and E. Izaurralde TAP (NXF1) belongs to a multigene family of putative RNA export factors with a conserved modular architecture Mol. Cell. Biol. 20 2000 8996 9008
41. J. Katahira, K. Strasser, A. Podtelejnikov, M. Mann, J.U. Jung, and E. Hurt The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to human EMBO J. 18 1999 2593 2609
42. S. Rodriguez-Navarro, and E. Hurt Linking gene regulation to mRNA production and export Curr. Opin. Cell Biol. 23 2011 302 309
43. D.N. Ho, G.A. Coburn, Y. Kang, B.R. Cullen, and M.M. Georgiadis The crystal structure and mutational analysis of a novel RNA-binding domain found in the human Tap nuclear mRNA export factor Proc. Natl. Acad. Sci. U. S. A. 99 2002 1888 1893
44. E. Liker, E. Fernandez, E. Izaurralde, and E. Conti The structure of the mRNA export factor TAP reveals a cis arrangement of a non-canonical RNP domain and an LRR domain EMBO J. 19 2000 5587 5598
45. R. Reed, and E. Hurt A conserved mRNA export machinery coupled to pre-mRNA splicing Cell 108 2002 523 531
46. M. Stewart Nuclear export of mRNA Trends Biochem. Sci. 35 2010 609 617
47. I.C. Braun, E. Rohrbach, C. Schmitt, and E. Izaurralde TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus EMBO J. 18 1999 1953 1965
48. G. Yatherajam, W. Huang, and S.J. Flint Export of adenoviral late mRNA from the nucleus requires the Nxf1/Tap export receptor J. Virol. 85 2011 1429 1438
49. V. Arya, W.W. Carter, and S.M. Robertson The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir Clin. Pharmacol. Ther. 88 2010 587 589
50. C.N. Serhan Pro-resolving lipid mediators are leads for resolution physiology Nature 510 2014 92 101
51. W.J. Lukiw, J.G. Cui, V.L. Marcheselli, M. Bodker, A. Botkjaer, K. Gotlinger, C.N. Serhan, and N.G. Bazan A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease J. Clin. Invest. 115 2005 2774 2783
52. B.D. Levy, N.W. Lukacs, A.A. Berlin, B. Schmidt, W.J. Guilford, C.N. Serhan, and J.F. Parkinson Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism FASEB J. 21 2007 3877 3884